Patent ID: 8076144
Filing Date: 2011-12-13
Classification: G01N

Abstract:
1. A method of preparing an individualized ischemic event risk assessment and individualized treatment for a subject, the method comprising: measuring by thrombelastography a first blood sample portion obtained from a subject to determine a first clot characteristic related quantitative indication of hemostasis of the first blood sample portion; determining a parameter indicative of the risk of the subject having an ischemic event based upon the first clot characteristic related quantitative indication of hemostasis and determining a treatment for the subject based upon the parameter; measuring by thrombelastography a second blood sample portion obtained from the subject post in vivo administration of a hemostasis therapy to determine a second clot characteristic related quantitative indication of hemostasis of the second blood sample portion; and determining a post therapy parameter indicative of the risk of the subject having an ischemic event based upon the second clot characteristic related quantitative indication of hemostasis and determining an efficacy of the hemostasis therapy for the subject based upon the parameters.